| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
5
4-Isomerase Activity Associated with the Human 17ß-Hydroxysteroid Dehydrogenase Type 2 Isoform1
Department of Pathology, Tohoku University School of Medicine (T.S., H.S.), Sendai 980-8575, Japan; Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center (S.A.), Dallas, Texas 75235; and Department of Reproductive and Developmental Sciences (Clinical Biochemistry), University of Edinburgh (J.I.M.), Edinburgh, United Kingdom EH3 9YW
Address all correspondence and requests for reprints to: Prof. J. Ian Mason, Department of Reproductive and Developmental Sciences (Clinical Biochemistry), University of Edinburgh, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh, United Kingdom EH3 9YW. E-mail: j.i.mason{at}ed.ac.uk
The type 2 isoform of human 17ß-hydroxysteroid dehydrogenase
(17ßHSD2) efficiently catalyzes the oxidative metabolism of androgens
and estrogens, and it is expressed in a large series of human
peripheral tissues. To obtain a better understanding of the regulation
of local steroid biosynthesis and metabolism in human tissues, we have
established a dual steroidogenic activity of the 17ßHSD2 enzyme after
transfection of human 17ßHSD2-transfected human embryonic kidney
(293) cells. After transient transfection, the metabolism of
testosterone, pregnenolone, and dehydroepiandrosterone
(DHEA) in intact transfected 293 cells was evaluated by
TLC-based radiometric assays. 17ßHSD2-transfected cells converted
91% of testosterone (1 µmol/L) into androstenedione in a 2-h
incubation period. In addition, pregnenolone (1 µmol/L) was converted
to progesterone (18.5%), whereas DHEA (1 µmol/L) was
metabolized to androstenedione (8.3% conversion) in a 15-h incubation
period. The kinetics of the 3ß-hydroxysteroid dehydrogenase
(3ßHSD) and 17ßHSD2 activities using cell homogenate protein of
stably transfected 293 cells indicated that the catalytic efficiency
(apparent catalytic efficiency = maximum velocity/Km)
of this 3ßHSD activity is approximately 2000-fold (pregnenolone as
substrate) or 3000-fold (DHEA as substrate) weaker than
that of 17ßHSD2 activity. It is noteworthy, however, that the
apparent catalytic efficiency of the HSD3B2 gene product is only
approximately 50-fold higher than that of the 3ßHSD aspect of the
17ßHSD2 gene product. Pregnenolone or DHEA effectively
inhibited 17ßHSD2 activity in a noncompetitive fashion. Furthermore,
the potent 5
-reductase/3ßHSD inhibitor,
17ß-N,N-diethylcarbamoyl-4-methyl-4-aza-5
-androstane-3-one,
inhibited neither 3ßHSD nor 17ßHSD2 activities. We conclude that
human 17ßHSD2 enzyme exhibits 3ßHSD activity. Notwithstanding that
this 3ßHSD activity is reduced compared to 17ßHSD oxidative
activity, it may account for at least some of the reports of 3ßHSD
activity found in human peripheral tissues that express notable amounts
of the 17ßHSD2 isozyme as well as in individuals with severe classic
3ßHSD deficiency.
This article has been cited by other articles:
![]() |
T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuchi, and H. Sasano Sex steroid-producing enzymes in human breast cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 701 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |